NeurAxis, Inc.
(NYSE Mkt: NRXS)
NeurAxis, Inc. engages in the provision of neuromodulation therapies to address chronic and debilitating conditions in children. Its product, IB-Stim, is a non-surgical device that works by sending gentle electrical impulses into cranial nerve bundles located in the ear. The company was founded by Gary Peterson and Christopher Robin Brown in 2011 and is headquartered in Carmel, IN.
2.735
+0.025
(+0.92%)
Range
2.730 - 2.755
(0.92%)
Open
2.740
Previous Close
2.710
Bid Price
-
Bid Volume
-
Ask Price
-
Ask Volume
-
Volume
3,258
Value
-
Remark
View All Events
Loading Chart...
Please login to view stock data and analysis